{
}
UBS has maintained its "Buy" rating for Shell, setting a target price of 3150 pence following a recent capital market event. Analyst Joshua Stone highlighted the positive impact of a higher payout ratio, reduced capital expenditure, and an increased cost reduction target for the oil and gas producer.
UBS has downgraded Douglas from "Buy" to "Neutral," reducing its price target from 25.50 to 11.50 euros. Analyst Yashraj Rajani cited the slowdown in the beauty care market, along with slower growth and deleveraging, as key reasons for the downgrade, despite the poorer outlook being reflected in the share price.
UBS has downgraded Douglas from "Buy" to "Neutral," slashing its price target from 25.50 to 11.50 euros. Analyst Yashraj Rajani cited the company's vulnerability to the beauty care market slowdown, leading to significantly reduced sales and earnings estimates. Despite the negative outlook, the recent share price decline has already factored in these challenges.
UBS has downgraded Douglas from "Buy" to "Neutral," reducing its price target from 25.50 to 11.50 euros. Analyst Yashraj Rajani cited the company's vulnerability to the slowing beauty care market, leading to significant cuts in sales and earnings estimates. Despite the downgrade, he noted that the negative outlook is now reflected in the share price.
UBS has rated Fresenius SE as 'Buy', indicating a positive outlook on the stock. However, the information provided is for informational purposes only and does not constitute a recommendation to buy or sell. Investors are cautioned about the risks involved in purchasing securities, which may lead to total capital loss.
UBS has increased its price target for Fresenius from 40 to 47 euros while maintaining a "Buy" rating. Analyst Graham Doyle emphasized that the company's focus is shifting towards value creation rather than merely avoiding losses, and he believes that current market expectations are overly pessimistic regarding the biosimilars sector.
UBS has downgraded Douglas from "Buy" to "Neutral," reducing its price target from €25.50 to €11.50. Analyst Yashraj Rajani cited the company's vulnerability to the beauty care market slowdown, leading to significantly lower sales and earnings estimates. Despite the negative outlook, the recent share price decline has already factored in these challenges.
UBS has increased its target price for Fresenius SE from 40 to 47 euros while maintaining a "Buy" rating. Analyst Graham Doyle emphasized that the company's focus is shifting towards value creation rather than merely avoiding losses, and he believes that current market expectations are overly pessimistic, particularly regarding the biosimilars sector.
UBS has downgraded Douglas from "Buy" to "Neutral," slashing its price target from 25.50 to 11.50 euros. Analyst Yashraj Rajani cited the company's vulnerability to the beauty care market slowdown, leading to significantly reduced sales and earnings estimates. Despite the downgrade, the negative outlook is now reflected in the share price.
UBS has maintained a "Neutral" rating for Nestlé SA, setting a target price of 80 francs ahead of the first quarter results. Analyst Guillaume Delmas has increased the organic growth estimate for the food group, although it remains below consensus expectations. The company’s shares are currently priced at 93.42 EUR, reflecting a decline of 0.64%.
European Securities and Markets Authority
SubCategory
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
UBS maintains buy rating for Shell with target price of 3150 pence
09:03 26.03.2025
UBS downgrades Douglas to neutral and cuts price target to 11.50 euros
08:42 26.03.2025
UBS downgrades Douglas to neutral and cuts price target significantly
07:35 26.03.2025
UBS downgrades Douglas to neutral and cuts price target to 11.50 euros
07:35 26.03.2025
ubs rates fresenius se as buy amid investment considerations and risks
07:21 26.03.2025
ubs raises fresenius price target to 47 euros maintains buy rating
07:21 26.03.2025
UBS downgrades Douglas to neutral amid beauty market slowdown
07:20 26.03.2025
ubs raises fresenius target price to 47 euros maintains buy rating
07:08 26.03.2025
ubs downgrades douglas to neutral and cuts price target to 11.50 euros
06:37 26.03.2025
ubs maintains neutral rating for nestle with target price of 80 francs
16:57 25.03.2025
Trending
Subcategory
Corporate News
Stock Market Updates
Industry Trends
Banking Regulations
Finance Mergers & Acquisitions
Global Financial Events
Retail and Consumer Goods
CEO Changes
Industry Mergers & Acquisitions
Central Bank Actions
Global Trade Developments
GDP Growth & Recession Forecasts
Financial Scams and Security
Market Analysis and Predictions
Inflation and Monetary Impact
Workplace Trends
Government Policies
Government Economic Policies
Startups & Entrepreneurship
Supply Chain Management
Countries:
Companies:
The Goldman Sachs Group, Inc.
JPMorgan Chase & Co.
Tesla, Inc.
Barclays PLC
Apple Inc.
Bank of America Corporation
Deutsche Bank Money Market PP
Wells Fargo & Company
Citigroup Inc.
Morgan Stanley
BNP Paribas SA
Huawei Technologies CO. Ltd.
Lloyds Banking Group plc
Credit Suisse Lux Digital Healt
Banco Santander, S.A.
Microsoft Corporation
UBS Group AG
UniCredit S.p.A.
Amazon.com, Inc.
HSBC Holdings plc
Currencies:
United States Dollar
Euro
Chinese Yuan
British Pound Sterling
Swiss Franc
Japanese Yen
Indian Rupee
Australian Dollar
Russian Ruble
Canadian Dollar
Offshore Chinese Yuan
United Arab Emirates Dirham
Indonesian Rupiah
Saudi Riyal
South Korean Won
Danish Krone
Turkish Lira
Hong Kong Dollar
Mexican Peso
Malaysian Ringgit
People: